Company Filing History:
Years Active: 1993
Title: The Innovative Contributions of Dipak C Chatterjee
Introduction
Dipak C Chatterjee is a notable inventor based in Bombay, India. He has made significant contributions to the field of pharmaceuticals, particularly in the fight against malaria. His innovative work has the potential to improve therapeutic outcomes for patients suffering from this disease.
Latest Patents
Chatterjee holds a patent for a pharmaceutical combination aimed at the prophylaxis and therapy of malaria. The patent details combinations of malaria therapeutics such as artemisinin, dihydroartemisinin, arteether, artemether, artesunate, and other artemisinin derivatives. These are combined with antimalarials like chloroquine, 10-0-methylfloxacrine, quinine, mefloquine, amodiaquine, pyrimethamine, sulfadoxine, and primaquine. The invention highlights the synergistic actions achieved when using subcurative doses of these individual substances, which can enhance treatment efficacy in mammals, including humans.
Career Highlights
Chatterjee is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical sector. His work there has focused on developing innovative solutions to combat malaria, showcasing his commitment to improving public health.
Collaborations
Chatterjee has collaborated with notable colleagues such as Bindumadhavan Venugopalan and Bansi Lal. These partnerships have likely contributed to the advancement of his research and the successful development of his patent.
Conclusion
Dipak C Chatterjee's contributions to malaria therapeutics through his innovative patent demonstrate his dedication to addressing critical health challenges. His work continues to inspire advancements in pharmaceutical research and development.